RANIBIZUMAB

Overview

RANIBIZUMAB is a Schedule H drug.
Ranibizumab is made from a human antibody fragment. It works by keeping new blood vessels from forming under the retina (a sensory membrane that lines the inside of the eye). In people with certain types of eye disorders, new blood vessels grow under the retina where they leak blood and fluid. Ranibizumab ophthalmic (for the eyes) is used to treat the "wet form" of age-related macular degeneration. Ranibizumab is also used to treat swelling in the retina caused by diabetes or a blockage in the blood vessels.

Usage

RANIBIZUMAB is generally used to treat: Macular Degeneration

Frequently Asked Questions

Q: Is it safe on my liver?
A: Check with your Doctor first

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

How Do I Take It?

Route of Administration: Ophthalmic (Eye)

Precautions

Caution should be exercised in patients with history of increased eye pressure, undergone for light therapy, any allergy, who are taking other medications, during pregnancy and breastfeeding. It may cause vision changes, do not drive a car or operate machinery while taking this medication. Perform eye exams regularly while taking this medication.

Common Side-Effects

RANIBIZUMAB : Dizziness, Eyes Pain, Head Headache, Irregular Heartbeat, Nasal Congestion, Runny Nose, Throat Soreness, Weight Loss (unintentional)

Serious Side-Effects

RANIBIZUMAB : Stroke, Heart Attack, BLOOD CLOT, Sudden Numbness Or Weakness On One Side Of Body, Slurred Speech, Confusion

Rare Side-Effects

RANIBIZUMAB : Skin Rash, Difficulty Breathing, Face Swelling, Body Itching

Disease Interactions

RANIBIZUMAB can interfere with: Uveitis, Optic Neuritis, Glaucoma

Technical Classification

RANIBIZUMAB is categorized as: ANTI-ANGIOGENIC OPHTHALMIC AGENTS / OPHTHALMIC PREPARATIONS / TOPICAL AGENTS

Storage Conditions

Room Temperature (Between 15 To 25 C)

Available Alternatives

Common Drugs with RANIBIZUMAB as Ingredient

LUCENTIS 0.5MG INJRANIBIZUMAB 0.5 MG